Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study

Osteoprotegerin (OPG) is a marker of vascular calcification and cardiovascular risk in patients with chronic kidney disease (CKD). This study aimed to compare and correlate OPG values with flow-mediated dilation (FMD) and pulse wave velocity (PWV) measurements in patients in stage 3 CKD and those wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arquivos brasileiros de cardiologia 2024-10, Vol.121 (11), p.e20240122
Hauptverfasser: Matos, Thalita de Oliveira, Vitorino, Priscila Valverde de Oliveira, Orlow, Rogerio, Melo, Átila de Oliveira, Amorim, Diogo da Silva, Sousa, Gleidson Junio Oliveira, Jorgetti, Vanda, Sousa, Ana Luiza Lima, Bezerra, Rodrigo, Barroso, Weimar Kunz Sebba
Format: Artikel
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page e20240122
container_title Arquivos brasileiros de cardiologia
container_volume 121
creator Matos, Thalita de Oliveira
Vitorino, Priscila Valverde de Oliveira
Orlow, Rogerio
Melo, Átila de Oliveira
Amorim, Diogo da Silva
Sousa, Gleidson Junio Oliveira
Jorgetti, Vanda
Sousa, Ana Luiza Lima
Bezerra, Rodrigo
Barroso, Weimar Kunz Sebba
description Osteoprotegerin (OPG) is a marker of vascular calcification and cardiovascular risk in patients with chronic kidney disease (CKD). This study aimed to compare and correlate OPG values with flow-mediated dilation (FMD) and pulse wave velocity (PWV) measurements in patients in stage 3 CKD and those without renal dysfunction. This case-control study was conducted in a specialized hypertension center in 2022. A total of 79 patients over 18 years of age participated in the study. The case group consisted of 30 patients with moderate renal dysfunction (CKD stage 3) and the control group included 49 individuals with glomerular filtration rate ≥ 60 mL/min/1.73 m2. The significance level adopted in the statistical analysis was 5%. Central pulse pressure (cPP), PWV, and augmentation index (AIx) were higher in patients with renal dysfunction. The serum OPG level positively correlated with peripheral and central systolic blood pressure, cPP, PWV, and AIx. Conversely, the serum OPG did not correlate with FMD. OPG and PWV are possible biomarkers of vascular dysfunction that are altered in patients with moderate renal dysfunction. Despite limitations of this study, including that it was a case-control study conducted at a single center, it has the potential, as a proof of concept, to generate the hypothesis of OPG and PWV as biomarkers of early vascular damage in this population.
doi_str_mv 10.36660/abc.20240122
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3133738956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3133738956</sourcerecordid><originalsourceid>FETCH-LOGICAL-p569-c0319d011f76d87b95d601eaad55e7d984a6f1bbad652411faabdc442a8060933</originalsourceid><addsrcrecordid>eNpNkEtLw0AUhQdRrFaXbmWWblLnkcwk7krqCwsVLW7DTWbSjqQzNTNB8jf8xUat0NU9cD4-OBehC0omXAhBrqGsJoywmFDGDtAJFTKNYirJ4V4eoVPv3wlhTPLkGI14JoikIjtBXwsftNu2LuiVbo3FYBV-A191DbR41vu6s1UwzuKhe4ZgtA0ef5qwxq8BVhpznK9bZ02Fn4yyuscz4zV4_Start2QfmjXBfyiLTT7zhs8xfnARrmzoXXNoOxUf4aOami8Pt_dMVre3S7zh2i-uH_Mp_Nom4gsqginmSKU1lKoVJZZogShGkAliZYqS2MQNS1LUCJh8YABlKqKYwYpESTjfIyu_rTD-I9O-1BsjK9004DVrvMFp5xLnmaJGNDLHdqVG62KbWs20PbF_xv5N2Rrdh4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3133738956</pqid></control><display><type>article</type><title>Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Matos, Thalita de Oliveira ; Vitorino, Priscila Valverde de Oliveira ; Orlow, Rogerio ; Melo, Átila de Oliveira ; Amorim, Diogo da Silva ; Sousa, Gleidson Junio Oliveira ; Jorgetti, Vanda ; Sousa, Ana Luiza Lima ; Bezerra, Rodrigo ; Barroso, Weimar Kunz Sebba</creator><creatorcontrib>Matos, Thalita de Oliveira ; Vitorino, Priscila Valverde de Oliveira ; Orlow, Rogerio ; Melo, Átila de Oliveira ; Amorim, Diogo da Silva ; Sousa, Gleidson Junio Oliveira ; Jorgetti, Vanda ; Sousa, Ana Luiza Lima ; Bezerra, Rodrigo ; Barroso, Weimar Kunz Sebba</creatorcontrib><description>Osteoprotegerin (OPG) is a marker of vascular calcification and cardiovascular risk in patients with chronic kidney disease (CKD). This study aimed to compare and correlate OPG values with flow-mediated dilation (FMD) and pulse wave velocity (PWV) measurements in patients in stage 3 CKD and those without renal dysfunction. This case-control study was conducted in a specialized hypertension center in 2022. A total of 79 patients over 18 years of age participated in the study. The case group consisted of 30 patients with moderate renal dysfunction (CKD stage 3) and the control group included 49 individuals with glomerular filtration rate ≥ 60 mL/min/1.73 m2. The significance level adopted in the statistical analysis was 5%. Central pulse pressure (cPP), PWV, and augmentation index (AIx) were higher in patients with renal dysfunction. The serum OPG level positively correlated with peripheral and central systolic blood pressure, cPP, PWV, and AIx. Conversely, the serum OPG did not correlate with FMD. OPG and PWV are possible biomarkers of vascular dysfunction that are altered in patients with moderate renal dysfunction. Despite limitations of this study, including that it was a case-control study conducted at a single center, it has the potential, as a proof of concept, to generate the hypothesis of OPG and PWV as biomarkers of early vascular damage in this population.</description><identifier>ISSN: 1678-4170</identifier><identifier>EISSN: 1678-4170</identifier><identifier>DOI: 10.36660/abc.20240122</identifier><identifier>PMID: 39607169</identifier><language>eng ; por</language><publisher>Brazil</publisher><subject>Adult ; Aged ; Biomarkers - blood ; Blood Pressure - physiology ; Case-Control Studies ; Female ; Glomerular Filtration Rate - physiology ; Humans ; Male ; Middle Aged ; Osteoprotegerin - blood ; Pulse Wave Analysis ; Reference Values ; Renal Insufficiency, Chronic - blood ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - physiopathology ; Statistics, Nonparametric ; Vascular Stiffness - physiology</subject><ispartof>Arquivos brasileiros de cardiologia, 2024-10, Vol.121 (11), p.e20240122</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-5487-4649 ; 0000-0001-9719-3176 ; 0000-0002-1265-1930 ; 0009-0001-6344-6099</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39607169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matos, Thalita de Oliveira</creatorcontrib><creatorcontrib>Vitorino, Priscila Valverde de Oliveira</creatorcontrib><creatorcontrib>Orlow, Rogerio</creatorcontrib><creatorcontrib>Melo, Átila de Oliveira</creatorcontrib><creatorcontrib>Amorim, Diogo da Silva</creatorcontrib><creatorcontrib>Sousa, Gleidson Junio Oliveira</creatorcontrib><creatorcontrib>Jorgetti, Vanda</creatorcontrib><creatorcontrib>Sousa, Ana Luiza Lima</creatorcontrib><creatorcontrib>Bezerra, Rodrigo</creatorcontrib><creatorcontrib>Barroso, Weimar Kunz Sebba</creatorcontrib><title>Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study</title><title>Arquivos brasileiros de cardiologia</title><addtitle>Arq Bras Cardiol</addtitle><description>Osteoprotegerin (OPG) is a marker of vascular calcification and cardiovascular risk in patients with chronic kidney disease (CKD). This study aimed to compare and correlate OPG values with flow-mediated dilation (FMD) and pulse wave velocity (PWV) measurements in patients in stage 3 CKD and those without renal dysfunction. This case-control study was conducted in a specialized hypertension center in 2022. A total of 79 patients over 18 years of age participated in the study. The case group consisted of 30 patients with moderate renal dysfunction (CKD stage 3) and the control group included 49 individuals with glomerular filtration rate ≥ 60 mL/min/1.73 m2. The significance level adopted in the statistical analysis was 5%. Central pulse pressure (cPP), PWV, and augmentation index (AIx) were higher in patients with renal dysfunction. The serum OPG level positively correlated with peripheral and central systolic blood pressure, cPP, PWV, and AIx. Conversely, the serum OPG did not correlate with FMD. OPG and PWV are possible biomarkers of vascular dysfunction that are altered in patients with moderate renal dysfunction. Despite limitations of this study, including that it was a case-control study conducted at a single center, it has the potential, as a proof of concept, to generate the hypothesis of OPG and PWV as biomarkers of early vascular damage in this population.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Blood Pressure - physiology</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Glomerular Filtration Rate - physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Osteoprotegerin - blood</subject><subject>Pulse Wave Analysis</subject><subject>Reference Values</subject><subject>Renal Insufficiency, Chronic - blood</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><subject>Statistics, Nonparametric</subject><subject>Vascular Stiffness - physiology</subject><issn>1678-4170</issn><issn>1678-4170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtLw0AUhQdRrFaXbmWWblLnkcwk7krqCwsVLW7DTWbSjqQzNTNB8jf8xUat0NU9cD4-OBehC0omXAhBrqGsJoywmFDGDtAJFTKNYirJ4V4eoVPv3wlhTPLkGI14JoikIjtBXwsftNu2LuiVbo3FYBV-A191DbR41vu6s1UwzuKhe4ZgtA0ef5qwxq8BVhpznK9bZ02Fn4yyuscz4zV4_Start2QfmjXBfyiLTT7zhs8xfnARrmzoXXNoOxUf4aOami8Pt_dMVre3S7zh2i-uH_Mp_Nom4gsqginmSKU1lKoVJZZogShGkAliZYqS2MQNS1LUCJh8YABlKqKYwYpESTjfIyu_rTD-I9O-1BsjK9004DVrvMFp5xLnmaJGNDLHdqVG62KbWs20PbF_xv5N2Rrdh4</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Matos, Thalita de Oliveira</creator><creator>Vitorino, Priscila Valverde de Oliveira</creator><creator>Orlow, Rogerio</creator><creator>Melo, Átila de Oliveira</creator><creator>Amorim, Diogo da Silva</creator><creator>Sousa, Gleidson Junio Oliveira</creator><creator>Jorgetti, Vanda</creator><creator>Sousa, Ana Luiza Lima</creator><creator>Bezerra, Rodrigo</creator><creator>Barroso, Weimar Kunz Sebba</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5487-4649</orcidid><orcidid>https://orcid.org/0000-0001-9719-3176</orcidid><orcidid>https://orcid.org/0000-0002-1265-1930</orcidid><orcidid>https://orcid.org/0009-0001-6344-6099</orcidid></search><sort><creationdate>202410</creationdate><title>Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study</title><author>Matos, Thalita de Oliveira ; Vitorino, Priscila Valverde de Oliveira ; Orlow, Rogerio ; Melo, Átila de Oliveira ; Amorim, Diogo da Silva ; Sousa, Gleidson Junio Oliveira ; Jorgetti, Vanda ; Sousa, Ana Luiza Lima ; Bezerra, Rodrigo ; Barroso, Weimar Kunz Sebba</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p569-c0319d011f76d87b95d601eaad55e7d984a6f1bbad652411faabdc442a8060933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; por</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Blood Pressure - physiology</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Glomerular Filtration Rate - physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Osteoprotegerin - blood</topic><topic>Pulse Wave Analysis</topic><topic>Reference Values</topic><topic>Renal Insufficiency, Chronic - blood</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><topic>Statistics, Nonparametric</topic><topic>Vascular Stiffness - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matos, Thalita de Oliveira</creatorcontrib><creatorcontrib>Vitorino, Priscila Valverde de Oliveira</creatorcontrib><creatorcontrib>Orlow, Rogerio</creatorcontrib><creatorcontrib>Melo, Átila de Oliveira</creatorcontrib><creatorcontrib>Amorim, Diogo da Silva</creatorcontrib><creatorcontrib>Sousa, Gleidson Junio Oliveira</creatorcontrib><creatorcontrib>Jorgetti, Vanda</creatorcontrib><creatorcontrib>Sousa, Ana Luiza Lima</creatorcontrib><creatorcontrib>Bezerra, Rodrigo</creatorcontrib><creatorcontrib>Barroso, Weimar Kunz Sebba</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Arquivos brasileiros de cardiologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matos, Thalita de Oliveira</au><au>Vitorino, Priscila Valverde de Oliveira</au><au>Orlow, Rogerio</au><au>Melo, Átila de Oliveira</au><au>Amorim, Diogo da Silva</au><au>Sousa, Gleidson Junio Oliveira</au><au>Jorgetti, Vanda</au><au>Sousa, Ana Luiza Lima</au><au>Bezerra, Rodrigo</au><au>Barroso, Weimar Kunz Sebba</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study</atitle><jtitle>Arquivos brasileiros de cardiologia</jtitle><addtitle>Arq Bras Cardiol</addtitle><date>2024-10</date><risdate>2024</risdate><volume>121</volume><issue>11</issue><spage>e20240122</spage><pages>e20240122-</pages><issn>1678-4170</issn><eissn>1678-4170</eissn><abstract>Osteoprotegerin (OPG) is a marker of vascular calcification and cardiovascular risk in patients with chronic kidney disease (CKD). This study aimed to compare and correlate OPG values with flow-mediated dilation (FMD) and pulse wave velocity (PWV) measurements in patients in stage 3 CKD and those without renal dysfunction. This case-control study was conducted in a specialized hypertension center in 2022. A total of 79 patients over 18 years of age participated in the study. The case group consisted of 30 patients with moderate renal dysfunction (CKD stage 3) and the control group included 49 individuals with glomerular filtration rate ≥ 60 mL/min/1.73 m2. The significance level adopted in the statistical analysis was 5%. Central pulse pressure (cPP), PWV, and augmentation index (AIx) were higher in patients with renal dysfunction. The serum OPG level positively correlated with peripheral and central systolic blood pressure, cPP, PWV, and AIx. Conversely, the serum OPG did not correlate with FMD. OPG and PWV are possible biomarkers of vascular dysfunction that are altered in patients with moderate renal dysfunction. Despite limitations of this study, including that it was a case-control study conducted at a single center, it has the potential, as a proof of concept, to generate the hypothesis of OPG and PWV as biomarkers of early vascular damage in this population.</abstract><cop>Brazil</cop><pmid>39607169</pmid><doi>10.36660/abc.20240122</doi><orcidid>https://orcid.org/0000-0002-5487-4649</orcidid><orcidid>https://orcid.org/0000-0001-9719-3176</orcidid><orcidid>https://orcid.org/0000-0002-1265-1930</orcidid><orcidid>https://orcid.org/0009-0001-6344-6099</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1678-4170
ispartof Arquivos brasileiros de cardiologia, 2024-10, Vol.121 (11), p.e20240122
issn 1678-4170
1678-4170
language eng ; por
recordid cdi_proquest_miscellaneous_3133738956
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Aged
Biomarkers - blood
Blood Pressure - physiology
Case-Control Studies
Female
Glomerular Filtration Rate - physiology
Humans
Male
Middle Aged
Osteoprotegerin - blood
Pulse Wave Analysis
Reference Values
Renal Insufficiency, Chronic - blood
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - physiopathology
Statistics, Nonparametric
Vascular Stiffness - physiology
title Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A11%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteoprotegerin%20and%20Vascular%20Dysfunction%20in%20Patients%20with%20Stage%203%20Chronic%20Kidney%20Disease%20and%20Those%20without%20Renal%20Dysfunction:%20A%20Case-Control%20Study&rft.jtitle=Arquivos%20brasileiros%20de%20cardiologia&rft.au=Matos,%20Thalita%20de%20Oliveira&rft.date=2024-10&rft.volume=121&rft.issue=11&rft.spage=e20240122&rft.pages=e20240122-&rft.issn=1678-4170&rft.eissn=1678-4170&rft_id=info:doi/10.36660/abc.20240122&rft_dat=%3Cproquest_pubme%3E3133738956%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3133738956&rft_id=info:pmid/39607169&rfr_iscdi=true